Sinergi Inti Plastindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sinergi Inti Plastindo Tbk. trades at Rp122 (market cap 135.41B, 8.77M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 50.3K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Sinergi Inti Plastindo Tbk. is more actively traded (8.77M versus 50.3K). Which is the better fit depends on your goals.
| ESIP | OBAT | |
|---|---|---|
Market Cap | 135.41B | 164.65B |
Volume | 8.77M | 50.3K |
Lot | 87.69K | 503 |
Turnover | 1.06B | 12.13M |
Average Price | 121.34 | 241.18 |
Value | 1.06B | 12.13M |
Indicative Equilibrium Price | 123 | 238 |
Indicative Equilibrium Volume | 1.43K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Read more on ESIP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →